Day 11:10 am

  • Event Update: Cutting-Edge Converting at AACC Clinical Lab Expo

    AACC Clinical Lab Expo 2013

    AACC Annual Meeting


    Join Us in Houston 

    Plan to join the MicroMed Solutions division of LasX Industries in Houston, TX, July 28 – August 1 at the AACC Annual Meeting & Clinical Lab Expo. Visit booth #5747  during the Clinical Lab Expo to learn about the benefits of laser converting as a precision manufacturing solution for high-performance, next-generation microfluidic structures from prototype to large-scale production.

    New this year, LasX and Surnetics are pleased to announce that they have signed a Memorandum of Understanding to partner on the development of precision-cut microfluidic products that incorporate high-tolerance laser processing with Surnetics’ gradient coatings for use in the diagnostic, medical, and other life science markets.

    LasX is an industry leader in the process development and manufacturing of precision, high volume microfluidic products and offers a great deal of product design and manufacturing expertise to be combined with Surnetics’ experience in coatings and fluid flow optimization. Gradient coatings can be optimized with product design and precision laser manufacturing to produce simpler, lower cost devices that achieve much higher performance than ever before.

    See demonstrations of these new technologies in booth #5747. Contact us to schedule a meeting during the event.

    Learn, Network & Explore 

    Attend the AACC Annual Meeting & Clinical Lab Expo to connect with global leaders in clinical chemistry, molecular diagnostics, translational medicine, mass spectrometry, lab management, and other areas of breaking science in laboratory medicine.

    Last year the Clinical Lab Expo included more than 650 organizations occupying more than 1990 booths, showcasing more products in every clinical lab discipline than at any other expo. Learn more or register now.

    Will you be attending this year’s event? Tell us what you’re most looking forward to in the comments below.


    continue reading